Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
暂无分享,去创建一个
[1] B. Gerber. [Adjuvant endocrine treatment of breast cancer beyond St. Gallen 2003]. , 2003, Zentralblatt für Gynäkologie.
[2] C. Ohyama,et al. Natural killer cells attack tumor cells expressing high levels of sialyl Lewis x oligosaccharides , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Barsky,et al. Relationship of sialyl-Lewis(x/a) underexpression and E-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma. , 2002, The American journal of pathology.
[4] S. Barsky,et al. Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma , 2002, Oncogene.
[5] A. Cleton-Jansen. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? , 2001, Breast Cancer Research.
[6] G. Berx,et al. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression , 2001, Breast Cancer Research.
[7] T. Reimer,et al. Simultaneous immunohistochemical detection of tumor cells in lymph nodes and bone marrow aspirates in breast cancer and its correlation with other prognostic factors. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] H. Rochefort,et al. Cathepsin D in breast cancer: mechanisms and clinical applications, a 1999 overview. , 2000, Clinica chimica acta; international journal of clinical chemistry.
[9] Daniel S. Miller,et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. , 1999, Journal of the National Cancer Institute.
[10] Mike Clarke,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[11] Mike Clarke,et al. Tamoxifen for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[12] H. Höfler,et al. Clinical Impact of the Plasminogen Activation System in Tumor Invasion and Metastasis: Prognostic Relevance and Target for Therapy , 1997, Thrombosis and Haemostasis.
[13] G. Trinchieri,et al. Biology of Natural Killer Cells , 1989, Advances in Immunology.
[14] C. Carter,et al. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.
[15] I. Henderson,et al. Cancer of the breast: the past decade (second of two parts). , 1980, The New England journal of medicine.
[16] G. Bonadonna,et al. Patterns of Relapse and Survival in Operable Breast Carcinoma with Positive and Negative Axillary Nodes , 1978, Tumori.
[17] N. Wolmark,et al. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy. , 1975, Surgery, gynecology & obstetrics.
[18] G. Robbins,et al. Long‐term followup of breast cancer patients: The 30‐year report , 1974, Cancer.
[19] B. Fisher,et al. Number of lymph nodes examined and the prognosis of breast carcinoma. , 1970, Surgery, gynecology & obstetrics.
[20] U. Jeschke,et al. Cathepsin D expression in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. , 2003, Acta histochemica.
[21] A. Krüger,et al. Inhibition of the tumor-associated urokinase-type plasminogen activation system: effects of high-level synthesis of soluble urokinase receptor in ovarian and breast cancer cells in vitro and in vivo. , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[22] L. Liotta,et al. Cancer invasion and metastasis: positive and negative regulatory elements. , 1991, Cancer investigation.
[23] Donald E. Henson,et al. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989 .